Market Research Reports

Home Press Releases Nanomedicine Market to Reach US$177.60 billion by 2019 propelled by Technical Advancement

Nanomedicine Market to Reach US$177.60 billion by 2019 propelled by Technical Advancement



 
Posted on May 29, 2015
Transparency Market Research (TMR) has recently published a market study based on the global nanomedicine market, estimating the market to grow at a healthy CAGR of 12.3% during the period from 2013 to 2019 in order to reach US$177.60 billion by 2019.The study, titled “Nanomedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, reports that the global nanomedicine market stood at US$78.54 billion in 2012.

According to the report, technological advancement in the field of nanomedicine is the primary growth driver of the global nanomedicine market. Apart from this, rising support from various governments in terms of funds and increasing collaborations between enterprises for research and development in nanomedicine is also expected to boost growth of this market. On the other hand, the lack of a well-organized regulatory framework and the high costs associated with these drugs and devices are suppressing the nanomedicine market’s growth.In the report, the analysis of the global nanomedicine market is carried out on the basis of the application areas of nanomedicines, such as neurology, oncology, cardiovascular diseases, anti-inflammatory diseases, anti-infectives, and others. The market for oncology led the global nanomedicine market, capturing a 38.0% share of the overall industry in 2012. The huge amount of commercialized nanomedicine products utilized in the field of oncology has propelled the market to a significant extent.

                          
Analysts at TMR estimate the market for oncology to lead the global nanomedicine market during the forecast period, but the fastest growth is expected from application in cardiovascular diseases. The presence of a significant patient population and increasing demand for nanomedicine-based devices and drugs are likely to fuel market growth.The report studies the regional markets for nanomedicine in detail and concludes that North America, the market leader in 2012, is expected to maintain its leading position during the forecast period. The factor responsible for the dominance of this regional market is the presence of advanced healthcare infrastructure, which supports the development of nanomedicines. However, the market in Asia Pacific is showing exceptional potential and is projected to register the fastest growth at a 14.6% CAGR between 2013 and 2019.

The prevalence of diseases, coupled with rising awareness regarding healthcare, is driving the nanomedicine market in Asia Pacific. The rise in nanomedicine research funding and numerous research collaborations in developing economies such as India, China, and other Asian nations are also helping the region stand out in the global nanomedicines market. The markets in Europe and the Rest of the World are also anticipated to report healthy growth during the forecast period.

Browse the full Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/nanomedicine-market.html

Abbott Laboratories, CombiMatrix Corp, Mallinckrodt plc, Celgene Corporation, Johnson & Johnson, GE Healthcare, Merck & Co. Inc., Pfizer Inc., Nanosphere, Inc., Sigma-Tau Pharmaceuticals Inc., UCB SA, and Teva Pharmaceutical Industries Ltd. are some of the major players in the global nanomedicine market profiled in this research report.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
 

Share This Article!  


Related Report

Payment
Copyright @ Transparency Market Research